Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NVE Corp. (NVEC) notified of grant of VMRAM patent
8:01 AM EDT March 20, 2007
Co. announces it has been notified by the U.S. Patent and Trademark Office of the expected grant of a patent relating to Vertical Transport Magnetoresistive Random Access Memory. The co has been notified that the patent, titled "Radial field generating selection conductor device," will be issued today. The patent is number 7,193,286 and is the grant of a patent under the application published by the USPTO as number 2006-0022238. The new patent relates to addressing Vertical Transport MRAM arrays.
Source: Briefing.com
Lumera Secures Million-Dollar Contract for Wideband Optical Modulators
Tuesday March 20, 9:00 am ET
BOTHELL, Wash.--(BUSINESS WIRE)--Lumera Corporation (NASDAQ:LMRA - News), a leader in the emerging field of nanotechnology, announced today that it has been awarded an extension to a U.S. government contract to continue development of technologically advanced wideband optical modulators. The 12-month contract is valued at approximately $1.15 million; the overall contract value has now reached approximately $6.9 million.
"This is further validation of the superiority of our electro-optic devices and materials and, along with other Lumera government contracts, directly parallels our roadmap to commercial products," said Tom Mino, Chief Executive Officer of Lumera. "Being chosen is recognition of our performance in meeting the technical and financial milestones defined in the contracts."
Lumera is developing high-performance modulators which enable a new generation of fiber-optic systems that are expected to deliver increased bandwidth at competitive costs and use lower power than current devices.
About Lumera
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit www.lumera.com.
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.
Contact:
Lumera Corporation
Helene Jaillet, 425-398-6546
hjaillet@lumera.com
or
The Summit Group Communications
Todd Wolfenbarger, 801-595-1155
801-244-9600 cell
--------------------------------------------------------------------------------
Source: Lumera Corporation
ADDED
^NNZ ABAT.OB ABBI ACCL ACO ACUS ADEP AGR ALTI AMAT AMRI AMSC APPA ARWR DD BDSI BIPH.OB BPA CALP CBMX CBT CCMP CRIS CTKH.PK CTT CVX DD DSTI ELN EMFP.OB EMKR ENDP ENEI.OB EXFO FEIC FLML GE GM GMZP.PK IBM IFX IMMC INGN INTK.PK ISON INTC HW HIT HPQ JMAR KEI KOMG KOPN LAVA LMRA LRCX LU MFIC.OB MMM MTSC MVIS NANO NANX NGEN NNPP.OB NNGB.PK NNVC.PK NOK NVAX NVEC NVMI PANL PFCE.OB PHG POCI.OB SKYE SMMX SOTK.OB SPDV.OB SPL.AX STM TGAL TINY TSM USGA.OB UTEK VECO VITA VYTC.OB XDSL.OB
Stocks added to iBox at suggestion of posters on the thread (please posts request to add or change stocks/symbols):
NNBP.OB BUG.V BNIKF.PK ATKJ.PK XCDC.PK, PSDV INTK.PK CVV MFIC.OB NNLX.PK IMMFF.PK AVNA.OB
NNVC!
The one; the only one; the BIG one; the life saving one.
Added INTK.PK to iBox. Are there any other nanotech stocks missing up there?
^NNZ ABAT.OB ABBI ACCL ACO ACUS ADEP AGR ALTI AMAT AMRI AMSC APPA ARWR DD BDSI BIPH.OB BPA CALP CBMX CBT CCMP CRIS CTKH.PK CTT CVX DD DSTI ELN EMFP.OB EMKR ENDP ENEI.OB EXFO FEIC FLML GE GM GMZP.PK IBM IFX IMMC INGN INTK.PK ISON INTC HW HIT HPQ JMAR KEI KOMG KOPN LAVA LMRA LRCX LU MFIC.OB MMM MTSC MVIS NANO NANX NGEN NNPP.OB NNGB.PK NOK NVAX NVEC NVMI PANL PFCE.OB PHG POCI.OB SKYE SMMX SOTK.OB SPDV.OB SPL.AX STM TGAL TINY TSM USGA.OB UTEK VECO VITA VYTC.OB XDSL.OB
Stocks added to iBox at suggestion of posters on the thread (please posts request to add or change stocks/symbols):
NNBP.OB BUG.V BNIKF.PK ATKJ.PK XCDC.PK, PSDV INTK.PK CVV MFIC.OB NNLX.PK IMMFF.PK AVNA.OB
Yes, looked but didn't buy - don't know why not - it just didn't grab me enough, I guess - interesting though.
np, INTK - ever looked at that stock?
Y, I posted that right before the chart.
It is pink. Is there any recent share issuance? I didn't check other than the S-8 thread
INTK has news doc
INTK Chart
Industrial Nanotech, Inc. Announces Multi-Million Dollar Project with Brazilian Oil & Gas Giant Petrobras
Industrial Nanotech, Inc. (Pink Sheets:INTK), an emerging global leader in nanotechnology, announced today that Petrobras (NYSE:PBR), the Brazilian oil and gas giant, has requested production of 50,000 gallons of Nansulate® High Heat, the Company’s thermally insulating and corrosion protection coating, valued at more than $3.7 million.
This order is currently scheduled for delivery in June of 2007 and is the beginning of an anticipated strong revenue stream for the Company.
Stuart Burchill, CEO of Industrial Nanotech, Inc., states, “This is the result of technical discussions that began in June 2006 and included my visit in September 2006 to their headquarters in Rio de Janeiro, Brazil for a series of meetings. Our discussions included detailed explanations of the performance benefits of our Nansulate coatings for use throughout their facilities worldwide, as well as their request for us to develop a specialty product for a 105-mile pipeline project in Brazil. We have invested substantial resources into developing that specialty product for them and we are pleased that they have reciprocated by identifying applications for our Nansulate coating products in their facilities. Petrobras is an innovative, forward-thinking company that is receptive to new technologies and it has been a pleasure doing business with them.”
Francesca Crolley, VP of Operations and Marketing for Industrial Nanotech, Inc., continues, “The production and delivery of 50,000 gallons of Nansulate High Heat in their requested time frame is well within our capabilities. Petrobras has also requested technical and logistical support for the application of Nansulate to 51,510 square feet of surface area per day. We plan to station a technical staff person permanently in Brazil to oversee these ongoing projects as we continue to expand our working relationship with Petrobras.”
Petrobras, short for Petroleo Brasileiro S.A., is a government-owned Brazilian oil company that is one of the 15 largest oil companies in the world, leading the oil and gas sector in the development of the most advanced deepwater and ultra-deep water technology for oil production. The company controls oil and power industries assets and related business activities in 16 nations throughout Africa, North America, South America and Asia.
Industrial Nanotech Inc. is rapidly emerging as a global nanoscience solutions and research leader. The Company develops and commercializes new and innovative applications for nanotechnology. Additional information about the Company and its products can be found at their websites, (http://www.industrial-nanotech.com) and (http://www.nansulate.com).
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
For Industrial Nanotech, Inc., Naples
Investor Relations
Martin E. Janis & Company, Inc.
Beverly Jedynak, President, 312-943-1100 ext. 12
bjedynak@janispr.com
or
Media Inquiries
Martin E. Janis & Company, Inc.
Laura Grock, Vice President, 312-943-1100 ext. 13
lgrock@janispr.com
Source: Business Wire (March 19, 2007 - 8:37 AM EDT)
News by QuoteMedia
www.quotemedia.com
Lumera Corporation to Exhibit at OFC/NFOEC in Anaheim
BusinessWire - March 16, 2007 9:00 AM ET
Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of nanotechnology, announced today that it will be exhibiting at the Optical Fiber Communication Conference & Exposition and the National Fiber Optic Engineers Conference (OFC/NFOEC). The conference being held in Anaheim, California, begins on Sunday, March 25, 2007, and continues through Thursday, March 29, 2007. The conference is expected to draw 13,000 attendees from commercial, government, and research institutions. It is the premier international event for both the science and business of optical communications.
About Lumera
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit www.lumera.com.
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.
SOURCE: Lumera Corporation
The Summit Group Communications
Todd Wolfenbarger, 801-595-1155
Cell: 801-244-9600
Mon Mar 19 06:50:25 2007 ALTI has been initiated by Merriman Curhan Ford as a buy.
Source: Briefing.com
Nanotechnology Could Improve Health Care in Developing Countries
By Art Chimes
Washington - www.voanews.com
16 March 2007
Scientists say nanotechnology, which involves some of the smallest things on earth, could have a big impact in developing countries. And some of the biggest benefits could come in improving health.
Nanotechnology refers to the ability to manipulate materials on the nanometer scale.
How small is that? A nanometer is one-billionth of a meter - something like the length of a line,10 atoms long.
That's hard to grasp, so nanotech scientist Andrew Maynard explains it with an analogy. If you can imagine a child the size of the Moon, "a tennis ball will be something like 50 nanometers in diameter. Or the head of a pin will be one nanometer in diameter. So the difference in scale, going from human scale to the nanoscale, is the equivalent of taking the moon and putting the head of a pin on the moon."
Maynard is chief scientist at the Project on Emerging Nanotechnologies, part of the Woodrow Wilson Center in Washington. At a recent symposium, he said researchers have been using nanotechnology to create products like cosmetics and stain resistant clothing. But some of the most promising uses of nanotechnology are in the health field.
In sub-Saharan Africa each year, malaria kills a million children under the age of five. A big part of the malaria challenge is correctly diagnosing patients. Often, anti-malaria drugs are given without a proper diagnosis, to people who may not have malaria. That's not only wasteful, it contributes to drug resistance. Peter Singer of the University of Toronto says a nanotechnology called quantum dots could make it much easier to correctly diagnose malaria, instead of using the traditional method of examining a patient's blood under a microscope.
"The bottom line," says Singer, "is that changing the infrastructure from moderate infrastructure like microscopes, to minimal infrastructure, like the quantum dots I was showing you, saves hundreds of thousands of lives for malaria. So this is a serious public health issue at stake, just from a diagnostic."
Quantum dots can reveal the fine details of cell structures. Someday, the technique may be used for speedy disease diagnosis.
In addition to better diagnostics, nanotechnology could also help in treating disease. For example, as Piotr Grodzinski of the U.S. National Cancer Institute points out, it could help make existing medicines more effective. "You can develop techniques which allow [doctors] to deliver the therapeutic drug or therapeutic treatment locally to the tumor site, and in many cases use much lower dose of the drug, and by that means cause lower side effects."
Advances in nanotechnology are coming out of labs in the usual advanced countries. But scientists in developing and emerging countries - China, India and Brazil, for example - are also involved. However, as program moderator Jeff Spieler of the U.S. Agency for International Development cautioned, it's still a big step getting those innovations to some of the world's poorest people.
"This to some extent will depend on how many of the new innovations will actually be coming from the laboratories of less developed countries," said Spieler, "and then what is the likelihood of that these advances, even in those laboratories, will find their way into the indigenous populations of those countries and not be picked up by somebody else?"
Although nanotech experts stress the potential benefits from the new technology, they also concede that there are risks involved in working with these new nano materials. Andrew Maynard of the Woodrow Wilson Center acknowledged the uncertainties.
"If you look at the very simplest case of nanometer-size particles, we know they behave differently in the body and in the environment [compared] to larger, more conventional particles," Maynard explained. "So yes, there are going to be a whole new set of risk issues we need to address, and that's going to require quite a substantial investment in new science to understand what those risks are, but also how to translate and transform that information into effective and safe ways of using the technologies."
Among those at risk could be workers involved in manufacturing new nano-scale materials, as well as consumers, such as those taking nano-based medicines.
Alert Triggered for Sono-Tek Corp.
Sono-Tek Corp. (SOTK) Price Crossed Above Its 60 Day Moving Average
SOTK crossed above its 60 day moving average of $1.14 with a trade of $1.20 at 11:46 AM EDT, up 8.1% from the moving average.
Please note you will receive only one "Price Crosses its Moving Average" alert per day per stock which means that you will not get another 60 day moving average alert for SOTK.
Still adding to all 3!
Just had to grab that 1000 post!
MFIC is good but don't forget SOTK and CVV
MFIC.ob 2.20 with 10 million shares outstanding. With the CEO, Pfizer and a private investor now controlling almost 30% of MFIC's shares, that only leaves a very small amount of 7 million shares in the float. I am expecting record Q4 earnings to be reported shortly on the heels of its preannounced largest quarterly revenue figure. This news item and thin float could lead to an explosive upmove for the stock price. With the stock price above 2 the CEO is also seeking a national listing for the stock. IMO, MFIC is the most appealing profitable microcap in the nanotechnology landscape at this time.
An Opportunity for Harris & Harris?
The Motley Fool
By Jack Uldrich
March 14, 2007
In an article yesterday on the initial public offering market, The Wall Street Journal reported that companies are increasingly staging IPOs even though they're not yet profitable. Examples cited include Riverbed (Nasdaq: RVBD), Isilon (Nasdaq: ISLN), and, more recently, Clearwire (Nasdaq: CLWR).
The trend goes beyond just a few high-profile examples. In the first quarter of 2006, only 25% of the companies that went public were unprofitable. By the fourth quarter of last year, that figure had jumped to almost 50%, and in the first quarter of 2007, the number has risen to 62%.
This newfound aggressiveness owes partly to investors' fading memory of the dot-com craze of the late 1990s, and to their growing willingness to pay more for the prospect of fast growth.
Though I'm not advising you to jump on the bandwagon and start investing willy-nilly in unprofitable IPOs, one company could ulimately profit from this trend: Motley Fool Rule Breakers recommendation Harris & Harris (Nasdaq: TINY).
As a publicly traded venture capital firm, the company has most of its money invested in small private nanotech start-ups, including Molecular Imprint, Nantero, and Nanosys (among many others). And while I have no indication that any of these companies are, in fact, planning to go public, today's more risk-tolerant environment bodes well for the prospect that they might.
Molecular Imprints is already working with Motorola (NYSE: MOT) and KLA-Tencor (NYSE: KLAC); Nantero is believed to be supplying its technology to On Semiconductor; and Nanosys is in a partnership with Intel (Nasdaq: INTC). Such activity suggests that these companies have the potential for the type of growth that investors now appear willing to buy at a premium. If you agree, an investment in Harris & Harris might be a smart way to profit from this new trend.
Quick Take: More Fuzzy Math at Altair
The Motley Fool
By Seth Jayson (TMFbent)
March 14, 2007
Usually, the Yahoo! message boards for penny stocks like Altair Nanotechnologies (Nasdaq: ALTI) are worthless. The long and strong engage in their textbook demonstrations of confirmation bias and label anyone who disagrees a "basher."
But someone pointed out to me a very interesting "basher" post, which brings to light one of those bits of fuzzy math that has made me so skeptical of Altair over the years.
The recently released 10-K, which covers the period ended Dec. 31, notes the following, regarding the much-hyped sale of NanoSafe battery packs to Phoenix Motorcars.
"Product sales increased from $149,373 in 2005 to $961,380 in 2006 due to our first sales of battery packs to Phoenix Motorcars, Inc. Of the 11 battery packs ordered, four were shipped and seven were billed and held by us based upon the written request of Phoenix ..." [emphasis mine].
Now, compare that with Altair's Dec. 28 press release on this topic, which states, "Altair Nanotechnologies Inc. announced today that it shipped ten rapid charge, high power NanoSafe battery packs to Phoenix Motorcars, Inc. on schedule.... Altairnano's NanoSafe battery packs meet or exceed all performance specifications and the shipments were made on schedule and on time to Phoenix Motorcars," said Altairnano President and CEO Alan J. Gotcher Ph.D." [Again, emphasis mine.]
I don't know about you, but where I come from, four is not 11.
Altair seems to have realized that this looks funky, because if we look back to the 10-K, we see management waffling and explaining that, by its interpretation of accounting standards, not delivering the batteries really does count as delivering them. It states that the above-described non-delivery of the remaining seven battery packs "complied with the revenue recognition criteria described in the Securities and Exchange Commission 'Staff Accounting Bulletin No. 104 - Revenue Recognition in Financial Statements.'"
Uh-huh. But it sure doesn't pass the sniff test. Smells to me like Altair was stuffing the revenue channel at year-end to be able to show big top-line growth. And that's why I view any of management's projections and pronouncements to be suspect.
Beware, Altair, lest your portfolio become nanotized.
Good news for SOTK's textile nanotech coating applications:
Nanotechnology Presents Significant Commercial Opportunities for the Textile Industry
March 13, 2007 01:00 PM Eastern Daylight Time
DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c51975) has announced the addition of Nanotechnologies for Smart and Responsive Textiles to their offering.
Nanotechnology will allow for whole new textile constructions integrated into leading-edge applications for the use in the aerospace, automotive, construction, healthcare and sportswear industries. It presents a significant commercial opportunity for the textile industry, especially for health and medical applications, allowing for example round-the-clock patient monitoring.
This report describes nanotechnologies, nanomaterials, nanotechnology companies, universities and research centres related to smart and responsive textile applications. According to VDC, consumption in the smart and interactive textiles market is predicted to grow to US$720million by 2008. The main drivers were identified as their need in critical applications (e.g. health and survival), in luxury applications (with niche consumer markets), the practicality of some applications and the potential market size. Inhibitors on the other hand have been identified to be commercial prices, cost of material and a lack of standards.
This report describes nanotechnologies, nanomaterials, nanotechnology companies, universities and research centres related to nanotechnologies for smart and responsive textiles.
Areas covered include:
- Carbon nanotubes for electronic textiles
- Enhanced water and stain repellency
- E-Textiles for wearable sensing and actuation
- Shape memory polymers for intelligent textiles
- Magnetic nanofibres with anti-counterfeiting applications for clothing
- Nanofibres for aerospace, automotive, biomedical and orthopedic devices, textiles, ceramics, polymers, and advanced composites
- Nanofibres for wearable displays
- Bioactive wound dressings
- Nanofibres for protective textiles
- Textiles with new luminescent properties
- Enhanced colour fastness to fabric and textiles
- Self-cleaning Textiles
Topics Covered
1 Introduction
1.1 Current Applications
1.2 Future Applications
2 Protective Textiles
2.1 UV Protection
2.2 Hydrophilicity
2.3 Hydrophobicity, Water And Oil Repellence
2.4 Thermal Comfort
2.5 Flame Retardancy
2.6 Anti-Bacterialism
2.7 Electrical Conductibility
2.8 Abrasion Resistance
2.9 Mechanical Resistance
2.10 Biodefence
2.11 Technology Providers
2.11.1 Companies
2.11.2 Universities
2.11.3 Research Centres
3 Electronic Textiles
3.1 Technology Providers
3.1.1 Companies
3.1.2 Universities
4 Smart Textiles
4.1 Technology Providers
4.1.1 Companies
4.1.2 Universities
4.1.3 Research Centres
5 Glossary Of Terms
For more information visit http://www.researchandmarkets.com/reports/c51975
Contacts
Research and Markets
Laura Wood
Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com
Carbon Nanotube Chips Coming Soon
The days of silicon chips are numbered.
And soon they might be replaced by
carbon nanotubes. After a long stretch
of challenges, IBM researchers have
finally achieved a milestone by creating
an integrated circuit out a single carbon
nanotube. Integrated chips (IC) are used
to process and store information in a wide
range of electronic devices from PCs to cell
phones.
Initially, the problem was to create
transistors used in ICs. Once that hurdle
was crossed, Big Blue researchers faced the
challenge of figuring out a reliable way to
assemble the transistors to form an IC.
IBM researchers developed an 18-micron
(less than the thickness of a plastic bag) long
carbon nanotube with a 10-transistor ring
oscillator, a device typically used for testing
new manufacturing technologies. The
success of the research also proved to be
economical as only one nanotube was used
instead of multiple tubes.
The introduction of carbon nanotubes
will have two advantages. Firstly, the data
transfer rate will increase as electrical
current moves more freely and faster
through carbon nanotubes than silicon.
Secondly, it is indeed very small—one
carbon nanotube is 50,000 times thinner
than a strand of hair, which translates to
more data storage in less space and makes
it more energy effi cient and speedier.
It will take time for these chips to
appear as IBM intends to spend more time
on research.
Sourc: techshout.blogspot.com
This is the SOTK product line that I expect will see the additional demand from the next generation stents:
MediCoat for stent coating -
A table-top, fully-contained system designed to apply thin layers of polymer and drug coatings to arterial stents with high precision. The system incorporates motion control of the stent during the coating process and produces coatings having excellent uniformity. The MediCoat uses either the
Accumist or MicroMist nozzle systems, which are precision nozzle configurations used in applications where precise patterns of lines and dots are required.
Good start of the week for selected microcap nanotech stocks:
MFIC +4%
SOTK +6%
LMRA +24%
CVV +5%
NVEC +8%
US demand for nanotechnology medical products to approach $53 billion in 2011
Cleveland, OH
Posted on March 12th, 2007
The critical need for new or improved therapies for many medical conditions will
promote the adaptation of nanotechnology to an expanding number of
pharmaceuticals. The total market for nanomedicines will command strong growth
over the long term. Treatments based on humanized monoclonal antibodies,
nanopolymers and nanoproteins will drive gains, with compounds for cancer, heart
diseases, neurological disorders and viral infections leading new product introductions
and growth opportunities.
Advances in nanotechnology will also contribute significant improvements to the
quality and performance of medical diagnostic products. Nanosized monoclonal
antibody labels and DNA probes will greatly enhance the speed, accuracy, capabilities
and cost-effectiveness of in vitro diagnostic testing, drug discovery and medical
research procedures. Nanoparticle formulations of superparamagnetic iron oxide,
gadolinium, perfluorocarbon and specialty polymers will broaden in vivo imaging
capabilities. Several medical supplies and devices will emerge as key applications
for nanotechnology. Nanomaterials are already gaining significant demand as active
ingredients of burn dressings, bone cement, bone substitutes, and dental repair and
restoration products.
The greatest short-term impact of nanotechnology in health care will be in
therapies and diagnostics for cancer and central nervous system disorders.
Gradually, many other major diseases, as well as injuries, will be treated and detected
routinely by nanotechnology products. By 2016, nanoimplants will be widely employed
in orthopedic procedures and begin to gain experimental uses in tissue and neuron
regeneration. By 2021, nanotechnology will serve applications that extend into most
areas of critical and chronic care. Additionally, the development of monoclonal antibody and nanomaterial vaccines and, to a lesser extent, controlled-release nutritional preparations will create a large preventive medicine market.
####
About Nanotechnology in Healthcare
Nanotechnology in Healthcare (published 02/2007, 349 pages) is available for $4,500 from The Freedonia Group, Inc., 767 Beta Drive, Cleveland, OH 44143-2326. For further details, please contact Corinne Gangloff by phone 440.684.9600, fax 440.646.0484 or e-mail pr@freedoniagroup.com.
A limited license to use or reprint information from this news release is granted to you provided attribution for the same – including, if possible, the price of the report – is given to The Freedonia Group, Inc. (Cleveland, OH). We would also appreciate the courtesy of receiving a copy of the article or publication in which we appear.
For more information, please click here
Contacts:
Corinne Gangloff
phone 440.684.9600
fax 440.646.0484
pr@freedoniagroup.com
Copyright © The Freedonia Group, Inc
Alert Triggered for Lumera Corp.
Lumera Corp. (LMRA) Price Crossed Above Its 60 Day Moving Average
LMRA crossed above its 60 day moving average of $5.03 with a trade of $5.09 at 9:30 AM EDT, up 36.7% from the moving average. Although it is still higher on the day, it is now trading at $4.99 which is below the moving average.
Please note you will receive only one "Price Crosses its Moving Average" alert per day per stock which means that you will not get another 60 day moving average alert for LMRA.
Lumera Receives Order and Enters Into Agreement with Lockheed Martin
Monday March 12, 8:45 am ET
BOTHELL, Wash.--(BUSINESS WIRE)--Lumera Corporation (NASDAQ:LMRA - News), a leader in the emerging field of nanotechnology, announced today that it had received a purchase order from Lockheed Martin for Lumera's high electro-optic activity materials. The term of the agreement is until December 31, 2007, at which time Lockheed Martin will advise Lumera of its intentions regarding a commercial license for the materials.
"We are pleased that Lockheed Martin is interested in our polymer materials and expect that the materials will perform as anticipated," said Dr. Raluca Dinu, Director of Lumera's Electro-Optic Business Unit. "We look forward to developing a long-term relationship with Lockheed Martin."
About Lumera
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit www.lumera.com.
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.
Contact:
The Summit Group Communications
Todd Wolfenbarger, 801-595-1155
801-244-9600 cell
--------------------------------------------------------------------------------
Source: Lumera Corporation
Alert Triggered for FEI Co.
FEIC Reached a New 52 Week High at $35.01
FEIC rose 6.4% to a new 52 week high of $35.01. During the last 52 weeks, FEIC's price has ranged from $18.78 on August 10, 2006 to today's high of $35.01.
Additionally, over the last 12 months, FEIC has increased 70.78% while its peers in the Semiconductor Equipment industry increased 7.69%.
Please note you will receive only one "New 52 Week High" alert per day for FEI Co.
Today's Wall Street Journal (page D1) discusses the new generation of drug-eluting cardiac stents coming from Boston Scientific, Medtronic, Johnson & Johnson and Abbott Labs awaiting FDA approval. Upon the FDA's OK, these more advanced, safer stents should result in new demand for SOTK's drug coating applications equipment.
MFIC Investor Fact Sheet Updated:
http://www.mficcorp.com/mf_pdf/IFS13.pdf
SOTK News Article:
Nano Scale Coating Process Developed for Baking Sector
FoodProductionDaily.com
February 28, 2007
By Ahmed ElAmin
A US company claims to have developed a way to apply micro- and nano scale coating processes directly onto food products and their packaging materials.
Sono-Tek Corp. said it has started testing the processes for clients in the baked goods sector using its laboratory in Milton, New York.
"The new projects will provide Sono-Tek's food industry customers with economic benefits resulting from new capabilities to develop and introduce new food products to the market, and from cost savings through more efficient spraying systems," the company said.
The laboratory is equipped with Sono-Tek ultrasonic atomization and spraying systems. The lab also contains heat transfer, mass transfer, and electronic control devices. The laboratory's analytical instruments will be used for specifying the new micro and nano scale coating processes, the company stated.
Sono-Tek said it has already successfully demonstrated the process to clients in the baked goods sector. The company's ultrasonic spraying systems are being used to accurately put natural anti-bacterial coats on food products.
The process was also used with natural oils and various glazing and decorating compounds, the company said.
Christopher Coccio, Sono-Tek's chief executive and president said the process will later be extended to its other clients in the food sector, which includes global manufacturers.
"We are confident that successful testing projects with our clients will result in the sale of custom designed commercial systems to many of them," he said.
Sono-Tek develops and manufactures liquid spray products using its ultrasonic nozzle technology, which it claims offers savings over other systems currently used by food manufacturers.
Nanotechnology refers to the technique of controlling and manipulating matter at near atomic scales to create new processes, materials and devices.
Carbon Nanotubes Help Stop Spread of HIV
Mobile Magazine
By: Dave White
Tuesday February 27, 2007 7:29 AM PST -
If they keep going like this, carbon nanotubes will be able to wear a giant S on their chests. Their latest technological triumph is a potentially massive one, the ability to fight HIV.
Scientists at Stanford University have reported being able to use the nano-sized multitaskers for RNA interference, enabling an immune system wracked by the virus that causes AIDS to switch off the gene that controls the mechanism by which the disease spreads.
The problem up until now has been that such interference isn't effective enough because the RNA can't just burrow into cells on its own. It needs help. But cell membranes are notoriously stubborn and resistant to such tinkering—until now. Even though scientists still can't explain just how the carbon nanotubes got in there, they did report that the little RNA carriers delivered their payload to its destination and that the receptor proteins that helped spread AIDS decreased by 80 percent.
That's just the first step, although it's really a giant leap. What lies ahead is more testing and more refining and more head-scratching as to just how those nanotubes do what they do. The tests done so far have been outside a human body. What needs to be done next is in vivo experimentation.
Via technologyreview.com
Congrats. to NVEC holders on the buy recommendation made by Craig-Hallum. Similarly, another profitable nanotech microcap, MFIC.ob, is expecting an upgrade from Taglich Brothers based on significantly higher guidance of Q4 revenues. Two other profitable nanotech microcaps, CVV on the AMEX and SOTK.ob, do not have any analyst coverage but would have huge upmoves on the initiation of coverage with any buy recommendations IMO.
Big day for NVEC:
3:39 pm NVE Corp. Started At Buy At Craig-Hallum >NVEC Dow Jones Newswires
Alert Triggered for MFIC Corp
MFIC Reached a New 52 Week High at $2.49
MFIC rose 2.5% to a new 52 week high of $2.49. During the last 52 weeks, MFIC's price has ranged from $1.10 on August 10, 2006 to today's high of $2.49.
Please note you will receive only one "New 52 Week High" alert per day for MFIC Corp.
Re: CVV, MFIC and SOTK - Nanotechnology is in the embryonic stage similar to the PC in the Seventies, Biotech in the Eighties and the Internet in the Nineties. Explosive long-term global structural growth is anticipated from this sector over the next decade at a minimum. That is why I am sticking with long-term investments all of which are profitable and have significant nanotech IP including MFIC.ob, SOTK.ob and CVV on the AMEX.
From PharmaceuticalOnline.com regarding MFIC's MMR system:
Product Name:
MMR Multiple Stream Mixer Reactor
Product Description:
•Product Brochure: MMR Multiple Stream Mixer Reactor
Microfluidics offers prototypes of a new and remarkable Multiple Stream Mixer Reactor that utilizes Microfluidizer® technology to optimize the fast chemical reactions required in many of today's processes. Applications for the patented MMR include superconductors, abrasives, photographic emulsions, recording media, planarization media, and pigment synthesis. Early testing by a catalyst manufacturer shows that this technology achieves unprecedented control of microstructure size and uniformity.
Microfluidics seeks strategic partners who are interested in manufacturing nano-materials in a chemical reaction process controlled to the molecular level. The objectives of such a collaboration include developing commercial models, providing sample testing, and working to scaleup from laboratory to production volumes.
By: Microfluidics
http://www.pharmaceuticalonline.com/content/productshowcase/product.asp?docid=ae76d282-e30e-4000-9d2...
MFIC 2.40 with 10 million shares out. With the CEO, Pfizer and Mr. Daly controlling almost 30% of MFIC's shares, that only leaves a very small amount of 7 million shares in the float. I am expecting blowout Q4 earnings to be reported next month. This news item and thin float could lead to an explosive upmove into the high single digits to low double digits for the stock price. IMO, MFIC is the most appealing profitable microcap in the nanotech landscape at this time.
CVV is appearing with Airgas which is a $3 Billion company for nanotechnology gas delivery systems applications:
Airgas Offers Four Free Technical Seminars at PITTCON 2007
Technical Experts and Division Leadership Available for Customer/Media Questions
February 23, 2007 04:50 PM Eastern Time
Pittcon 2007
RADNOR, Pa.--(BUSINESS WIRE)--Airgas, Inc. (NYSE:ARG), the largest U.S. distributor of specialty gases and equipment, announced plans for the 2007 Pittsburgh Conference (PITTCON) to be held in Chicago from February 25-March 2, 2007. Four technical seminars will be held Monday, February 26 through Wednesday, February 28 at McCormick Place, Seminar Room 42, near the Airgas Exhibit (Booth # 3865).
The technical seminars being offered will provide participants with a greater understanding of consistent performance in the analytical laboratory through the following presentations:
Setting Up a Process Gas Stream
Lee Polite, President of Axion, Inc., and Sherri Pertee, Airgas’ Market Development Manager, will address the challenges of setting up new laboratory systems and how to overcome these challenges using Airgas’ new technology in gases and equipment, notably BIP® Technology, SIP™ purifiers, and SIR™ regulators. This session will be held Monday and Tuesday, 10:00 a.m. – 10:45 a.m.
Gas Delivery Systems for Nanotechnology
Gary Dyal, Manager of Marketing / Sales for CVD Equipment, and Frank Kandl, Equipment Marketing Manager for Airgas, will provide valuable information for selecting safe, modular, and cost-effective R&D systems designed for Nanotechnology research utilizing flammable, pyrophoric, and toxic gases and chemicals. This session will be held Monday, Tuesday and Wednesday, 11:00 a.m. – 11:45 a.m.
Carrier Gas Selection, Helium vs. Hydrogen
Len Sidisky, R & D Manager in Supelco’s Gas Separations Business Unit, and Frank Kandl, Airgas’ Equipment Marketing Manager, will compare the performance and effects of nitrogen, helium, and hydrogen on the speed of analysis, selectivity, resolution, sensitivity, and safety of use. This session will be held Monday, Tuesday, and Wednesday, 1:00 p.m. – 1:45 p.m.
Use of BIP® Helium on a Pulse Discharge Detector
Mike King, Chromatography Technology Manager for PAC, LP, and Sherri Pertee, Airgas’ Market Development Manager, will discuss the results of a recent study examining the difference in the capability of laboratory instrumentation when using higher purity carrier gas. This session will be held Wednesday, 10:00 a.m. – 10:45 a.m.
“PITTCON gives customers and prospective customers the opportunity to meet some of the most skilled and forward-thinking people in our industry,” said Jim Muller, Airgas’ recently appointed Senior Vice President of Specialty Gases and Life Science. “Airgas, as the industry leader in specialty gases, is pleased to make its technical experts available to customers. This open communication can help foster proper gas and equipment selection to ensure consistent performance in the analytical laboratory.”
Additional information on the Technical Seminars, as well as on Airgas’ specialty gas product, service, and equipment offerings, will be available at Airgas booth #3865.
About Airgas, Inc.
Airgas, Inc. (NYSE:ARG) is the largest U.S. distributor of specialty, medical and industrial gases, welding, safety and related products. More than 11,000 associates work in more than 900 locations nationwide, including branches, retail stores, gas fill plants, specialty gas labs, production facilities and distribution centers. Airgas also distributes its products and services through eBusiness, catalog, and telesales channels. Its national scale and strong local presence offer a competitive edge to its diversified customer base. For more information, please visit www.airgas.com.
Contacts
Airgas, Inc.
Investor Contact:
Jay Worley, 610-902-6206
jay.worley@airgas.com
or
Media Contact:
James Ely, 610-902-6010
jim.ely@airgas.com
MFIC under accumulation by new 5% owner:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
MFIC Corp.
---------------------------------------------
(Name of Issuer)
Common Stock, no par value
---------------------------------------------
(Title of Class of Securities)
595073107
---------------------------------------------
(CUSIP Number)
Joseph P. Daly
497 Circle Freeway
Cincinnati, Ohio 45246
(513) 943-7100
------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
February 12, 2007
------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. [ ]
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
<Table>
<S> <C> <C>
-----------------------------------------------------------------------------------------------------------
CUSIP No. 595073107 13D
-----------
-----------------------------------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
Joseph P Daly
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
-----------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [ ]
-----------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
PF
-----------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) [ ]
-----------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-----------------------------------------------------------------------------------------------------------
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICIALLY 505,700
------------------------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH REPORTING -0-
------------------------------------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
505,700
------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
505,700
-----------------------------------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ]
-----------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.00%
-----------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
IN
-----------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
ITEM 1. SECURITY AND ISSUER.
The class of equity security to which this statement relates is the
common stock (the "Common Stock"), no par value per share ("Share"), of
MFIC Corporation, a Newton, Massachuesetts corporation (the "Issuer"). The
address of the principal executive offices of the Issuer is 30 Ossipee Road,
PO Box 9101,Newton, MA 02464.
ITEM 2. IDENTITY AND BACKGROUND.
This statement is being filed by Joseph P Daly, by virtue of his
purchase of certain Shares and resulting beneficial ownership of greater than 5%
of the outstanding Shares of the Common Stock.
(a) NAME: The name of the reporting person is Joseph P. Daly.
(b) BUSINESS ADDRESS: The principal business address of Mr. Daly is
497 Circle Freeway, Cincinnati, Ohio 45246.
(c) PRINCIPAL OCCUPATION AND THE NAME, PRINCIPAL BUSINESS AND ADDRESS
OF ANY CORPORATION OR ORGANIZATION: Mr. Daly is the chief executive of
Essig Research Incorporated. Essig Research offers global engineering
services. Mr. Daly's principal business address is 497 Circle
Freeway, Cincinnati, Ohio, 45246.
(d) CRIMINAL PROCEEDINGS: During the past five years, Mr. Daly has not
been convicted in a criminal proceeding.
(e) SECURITIES LAWS: During the past five years, Mr. Daly has not been
a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction as a result of which such person is or was
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to,
federal or state securities laws or finding any violation with respect
to such laws.
(f) CITIZENSHIP: Mr. Daly is a United States citizen.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Mr. Daly has purchased an aggregate of 505,700 Shares for total
consideration of $744,408.19. Such funds were provided from
Mr. Daly's personal funds.
The information set forth in Item 4 of this Schedule 13D is hereby
incorporated herein by reference.
<PAGE>
ITEM 4. PURPOSE OF TRANSACTION.
Mr. Daly purchased the Shares for investment purposes. Mr. Daly is
continuing to review the performance of his investment and his
investment alternatives. As part of his ongoing review of his
investment in the Shares, Mr. Daly may explore from time to time a
variety of alternatives, including the acquisition of additional
securities of the Issuer or the disposition of securities of the Issuer
in the open market or in privately negotiated transactions. The
foregoing reflects activities presently contemplated by Mr. Daly with
respect to the Issuer, the foregoing is subject to change at any time,
and there can be no assurance that Mr. Daly will take any of the
actions referred to above.
Except as set forth in the preceding paragraph, as of the date hereof,
Mr. Daly does not currently have any plan or proposal that relates to
or would result in:
(a) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Issuer or any of its
subsidiaries;
(b) A sale or transfer of a material amount of assets of the Issuer or
any of its subsidiaries;
(c) Any change in the present board of directors or management of the
Issuer, including any plans or proposals to change the number or term
of directors or to fill any existing vacancies on the board;
(d) Any material change in the present capitalization or dividend
policy of the Issuer;
(e) Any other material change in the Issuer's business or corporate
structure;
(f) Changes in the Issuer's charter, bylaws or instruments
corresponding thereto or other actions which may impede the acquisition
of control of the Issuer by any person;
(g) Causing a class of securities of the Issuer to be delisted from a
national securities exchange or to cease to be authorized to be quoted
in an inter-dealer quotation system of a registered national securities
association;
(h) A class of equity securities of the Issuer becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Act; or
(i) Any action similar to any of those enumerated above.
Notwithstanding the foregoing, Mr. Daly reserves the right to effect
any such actions as he may deem necessary or appropriate in the future.
The information set forth in Item 3 of this Schedule 13D is hereby
incorporated herein by reference.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) AMOUNT BENEFICIALLY OWNED: As of the date hereof, Mr. Daly
beneficially owns an aggregate of 505,700 Shares. Based on the
10,104,366 Shares estimated to be outstanding on February 12, 2007
from the Issuer's quarterly report on Form 10QSB for the period
ended September 30, 2006 and the subsequent Form 4 filings, Mr. Daly
beneficially owns 5.00% of the outstanding Shares.
(b) NUMBER OF SHARES AS TO WHICH MR. DALY HAS :
(i) Sole power to vote or direct the vote: 505,700
(ii) Shared power to vote or direct the vote: 0
(iii) Sole power to dispose or direct the disposition of:
505,700
(iv) Shared power to dispose or direct the disposition of:
0
(c) TRANSACTIONS SINCE LAST FILING :
<PAGE>
<Table>
<Caption>
Person Who Effected the Transaction Transaction Date Number of Shares Purchased Price per Share
<S> <C> <C> <C>
Joseph P. Daly 12/21/2006 700 1.42
Joseph P. Daly 12/21/2006 3300 1.43
Joseph P. Daly 12/21/2006 600 1.45
Joseph P. Daly 12/22/2006 2400 1.46
Joseph P. Daly 12/26/2006 2000 1.50
Joseph P. Daly 12/26/2006 1000 1.53
Joseph P. Daly 12/26/2006 1450 1.58
Joseph P. Daly 12/27/2006 2575 1.56
Joseph P. Daly 12/27/2006 1000 1.55
Joseph P. Daly 12/28/2006 1000 1.54
Joseph P. Daly 12/28/2006 100 1.48
Joseph P. Daly 12/29/2006 1000 1.53
Joseph P. Daly 1/03/2007 3800 1.53
Joseph P. Daly 1/08/2007 200 1.55
Joseph P. Daly 1/09/2007 1300 1.50
Joseph P. Daly 1/09/2007 100 1.46
Joseph P. Daly 1/10/2007 770 1.53
Joseph P. Daly 1/11/2007 650 1.50
Joseph P. Daly 1/12/2007 3030 1.52
Joseph P. Daly 1/16/2007 270 1.44
Joseph P. Daly 1/17/2007 330 1.50
Joseph P. Daly 1/18/2007 475 1.55
Joseph P. Daly 1/22/2007 393 1.48
Joseph P. Daly 2/12/2007 325 1.85
Joseph P. Daly 2/12/2007 557 1.93
</Table>
All purchases were effected through unsolicited brokers'
transactions on the Nasdaq National Market.
(d) RIGHT TO RECEIVE OR POWER TO DIRECT: To the knowledge of Mr. Daly,
no person other than Mr. Daly has the right to receive or the power to
direct the receipt of dividends from, or proceeds from the sale of, the
shares of Common Stock beneficially owned by Mr. Daly.
(e) DATE REPORTING PERSON CEASED TO BE 5% OWNER: Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER.
None.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 22, 2007
/s/ Joseph P Daly
------------------------
Print Name: Joseph P Daly
</TEXT>
</DOCUMENT>
NNPP: Volume Spike; 7% > 20-adsv, Stock +18.18%
Friday , February 23, 2007 09:50ET
This is the 2nd VOLUME alert for NNPP in the past 7 calendar days.
Trading for Nano-Proprietary Inc (OTCBB: NNPP) has been heavier than usual in today's session. By 09:50 ET, the stock had already traded 181,900 shares via 63 trades. The cumulative volume is 6.80% above its 20-day average of 170,317. Normally the stock experiences around 78 individual trades per session.
So far, today's volume surge has caused a net rise in NNPP's stock price. At the time of this alert, the stock was trading at $1.690, up $0.260 (+18.18%).
One year ago, the Company's shares closed at $2.550. The price has declined more than 33 percent since then.
Over the last 10 trading session NNPP has traded in a range between $1.220 and $1.480 and is currently trading 36.94% below its 52-week high of $2.680 set on February 24,2006 and 83.50% above its 52-week low of $0.921 from November 09,2006.
In the previous 3 sessions, NNPP trading has displayed a mixed trend. Closing results have been as follows:
February 22, 2007 --- closed at $1.430 up $0.040 (+2.88%) on 68,340 shares
February 21, 2007 --- closed at $1.390 down $0.060 (-4.14%) on 134,200 shares
February 20, 2007 --- closed at $1.450 up $0.020 (+1.40%) on 255,300 shares
The Company has not released news in the past 30 days
NANO-PROPRIETARY INC
A nanotechnology company. Focuses efforts on research, proof of concept development for products, and licensing their technology to others.
SOTK 1.22 on the move this AM on nanotech food coatings technology news. Thin stock with only 14 million shares outstanding and excellent fundamentals:
Sono-Tek Announces 'Baked Goods Industry' Applications Testing
9:46 AM EST February 23, 2007
Sono-Tek Corporation (OTC Bulletin Board: SOTK) announced today that it has begun testing and process development projects for clients in the Baked Goods Industry, using its laboratory facility in Milton, New York, USA.
The laboratory is equipped with Sono-Tek proprietary ultrasonic atomization and spraying systems, as well as with versatile heat transfer, mass transfer, electronic control devices, and analytical instruments necessary for developing and specifying new micro/nano scale coating processes directly onto food products and/or their packaging materials.
The Baked Goods Industry projects are supervised by Joseph Riemer, PhD, VP of Engineering of Sono-Tek Corp. Dr. Riemer and his staff have received extensive training in the operation of ultrasonic spraying systems from Harvey Berger, PhD, the Company's Chief Technology Officer and the inventor of the Company's patented ultrasonic nozzle.
The new projects will provide Sono-Tek's Food Industry customers with economic benefits resulting from new capabilities to develop and introduce new food products to the market, and from cost savings through more efficient spraying systems. Sono-Tek has already successfully demonstrated to its Baked Goods Industry clients the ability of its ultrasonic spraying systems to accurately coat natural anti-bacterial solutions, natural oils and various glazing and decorating compounds.
"We are pleased to offer these services to our clients, which already include 'Fortune 500' global food manufacturing companies," said Dr. Christopher L. Coccio, Sono-Tek CEO and President. "We are confident that successful testing projects with our clients will result in the sale of custom designed commercial systems to many of them," he added.
Sono-Tek has helped numerous clients in reducing the amount of liquid material required by reducing overspray, with the additional benefit of producing thinner, more precisely controlled coatings of greater uniformity. These technological advantages of Sono-Tek systems provide Sono-Tek's customers both cost and environmental benefits over traditional spraying and coating systems.
For further information, contact Dr. Christopher L. Coccio, at 845-795-2020, or visit our website at www.sono-tek.com.
Sono-Tek Corporation is a leading developer and manufacturer of liquid spray products based on its proprietary ultrasonic nozzle technology. Founded in 1975, the Company's products have long been recognized for their performance, quality and reliability.
This press release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive and technological developments affecting the Company's operations or the demand for its products; timely development and market acceptance of new products; adequacy of financing; capacity additions and the ability to enforce patents. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-KSB and Form 10-QSBs containing additional important information.
SOURCE Sono-Tek Corporation
Dr. Christopher L. Coccio, +1-845-795-2020
http://www.sono-tek.com
Alert triggered on NNPP lol
Alert Triggered for MFIC Corp.
MFIC Reached a New 52 Week High at $2.46
MFIC rose 1.7% to a new 52 week high of $2.46. During the last 52 weeks, MFIC's price has ranged from $1.10 on August 10, 2006 to today's high of $2.46.
Please note you will receive only one "New 52 Week High" alert per day for MFIC Corp.
Lumera Corporation To Hold Conference Call To Discuss Q4 2006 Results
Thursday February 22, 2:40 pm ET
BOTHELL, Wash.--(BUSINESS WIRE)--Lumera Corporation (NASDAQ:LMRA - News), an emerging leader in the field of nanotechnology, will hold its quarterly conference call to discuss fourth quarter 2006 results on March 8, 2007 at 4:30PM Eastern Standard Time (1:30PM Pacific Standard Time).
Details to access the conference call and the live audio web cast are as follows:
Conference call
(Please call approximately ten minutes prior to the scheduled start of the call)
Toll-free: 866.825.1709
International callers: 617.213.8060
Pass code: 39340297
Live Audio web cast: www.Lumera.com
Replay and archive information:
(Telephone replay available until March 15, 2007 6:30 PM)
Toll-free: 888-286-8010
International callers: 617-801-6888
Pass code: 49339768
Web cast will be archived on the Company's website at www.Lumera.com
About Lumera
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit www.lumera.com.
Contact:
Lumera Corporation
Helene F. Jaillet (Investor Relations), 425-398-6546
or
The Summit Group Communications
Todd Wolfenbarger (Media), 801-595-1155
http://www.lumera.com
--------------------------------------------------------------------------------
Source: Lumera Corporation
From IHub VMC MB:
Posted by: gilead23
In reply to: shmoopy38 who wrote msg# 65721 Date: 2/22/2007 4:19:55 PM
Post #
MFIC agreed nice day
As I said before if you look at the backlog which rose 700k in a single month it implies orders were accelerating.
At a somewhat low sales rate of 1 million a month they would have signed 1.7 in new orders in january for a quarterly revenue rate of 5.1 million.
If you put the sales rate in line with what they had last quarter it implies they pulled in a whopping 2.4 million in orders in january alone for an implied quarterly revenue rate of over 7 million.
If they actually did that 7 million you would be looking at EPS numbers of .14 a quarter which I think would certainly make it a 5 bagger from here.
As it stands I am hoping they do 5 million/.06 eps followed by 6 million .09 EPS.
This was a nice pick. Thanks to those of you who brought it up.
From SI MB in response to a question about why MFIC's has been hitting new highs recently:
To: Diamono who wrote (33286) 2/22/2007 2:03:02 PM
From: Baton of 33292
Mainly because they had a huge quarterly profit increase and it looks like it is going to continue. I think MFIC is the purest nano play out there. I believe that if the sector gets some momo, and some institutional interest, we could see $8-10. No kidding. The low float and lack of sellers is working to our advantage. It is a mega winner IMO.
Baton
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |